Lixisenatide: a review of its use in patients with type 2 diabetes mellitus.
about
Adverse Effects of GLP-1 Receptor AgonistsEffects of lixisenatide on elevated liver transaminases: systematic review with individual patient data meta-analysis of randomised controlled trials on patients with type 2 diabetesOptimal therapy of type 2 diabetes: a controversial challengeThe extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems.Extra-pancreatic effects of incretin-based therapies.Cardiovascular safety and benefits of GLP-1 receptor agonists.Insulin Glargine/Lixisenatide: A Review in Type 2 Diabetes.Lixisenatide (Adlyxin): A Once-Daily Incretin Mimetic Injection for Type-2 Diabetes.
P2860
Q26801346-DA76D5D6-BC24-4E1C-AE81-1D7192FA1AEAQ27025423-1CD1D1E4-74B6-4B0C-A8B3-97DC6B9CE8A7Q33577712-A2FE424B-50A2-4F4D-A82E-C40296670599Q38174279-8A7F4778-DA26-4506-B7D7-B5988E830E94Q38194069-F0CEB4E6-EF28-41E4-AE13-422C491B3940Q39013056-655124A5-CB84-4239-9492-78CB3A36572BQ39408293-6E1121CF-A948-43DB-87A2-BC7F4C46592DQ47115430-15E645DD-994C-4AF8-BE46-ABB27BDD1881
P2860
Lixisenatide: a review of its use in patients with type 2 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lixisenatide: a review of its use in patients with type 2 diabetes mellitus.
@en
type
label
Lixisenatide: a review of its use in patients with type 2 diabetes mellitus.
@en
prefLabel
Lixisenatide: a review of its use in patients with type 2 diabetes mellitus.
@en
P2860
P1433
P1476
Lixisenatide: a review of its use in patients with type 2 diabetes mellitus.
@en
P2860
P2888
P304
P356
10.1007/S40259-013-0057-Y
P577
2013-10-01T00:00:00Z